Stem Pharm
The startup develops stem cell-derived in vitro models of the central nervous system using functionalized multi-arm polyethylene glycol monomers cross-linked with bioactive peptides to create hydrogels. These models provide researchers and clinicians with reliable cell-based assays for drug discovery and toxicology testing, addressing the need for more accurate disease modeling.
- Biotechnology
Updated 21 months ago
Funding
Raised to date
$500KRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup develops stem cell-derived in vitro models of the central nervous system using functionalized multi-arm polyethylene glycol monomers cross-linked with bioactive peptides to create hydrogels. These models provide researchers and clinicians with reliable cell-based assays for drug discovery and toxicology testing, addressing the need for more accurate disease modeling.